Murad S, Tajima S, Pinnell S R
Arch Biochem Biophys. 1985 Sep;241(2):356-63. doi: 10.1016/0003-9861(85)90557-0.
The effect of hydralazine on several parameters of collagen biosynthesis has been studied in cultured human skin fibroblasts. Cells treated with hydralazine synthesized procollagen which was severely deficient in hydroxyproline and hydroxylysine, indicating inhibition of prolyl and lysyl hydroxylase reactions in the cell. Assays of prolyl and lysyl hydroxylase activities, however, revealed markedly increased levels in hydralazine-treated cells. The stimulatory effect of hydralazine could not be simulated in cell extracts, demonstrating its requirement for intact cells. The effect occurred slowly over a period of 96 h and was dependent on hydralazine concentration between 10 and 100 microM. This phenomenon was also observed in lysyl hydroxylase-deficient mutants. In both normal and mutant cells the relative magnitude of the hydralazine effect could be modified by ascorbic acid in the culture medium. Ascorbic acid increased the response of prolyl hydroxylase to hydralazine from 1.5- to 2-fold to 3- to 7-fold, whereas it decreased the response of lysyl hydroxylase to hydralazine from 4- to 8-fold to 2- to 3-fold. Total collagen synthesis was substantially reduced in hydralazine-treated cells; the time course and the dose-response relationship were similar to those observed for the hydroxylases. alpha, alpha'-Dipyridyl, an iron chelator, mimicked these effects of hydralazine. The studies suggest the existence in cultured cells of a compensatory mechanism for overproduction of these crucial enzymes in collagen biosynthesis, a mechanism which remains functional in cells derived from patients afflicted with hydroxylysine-deficient collagen disease.
已在培养的人皮肤成纤维细胞中研究了肼屈嗪对胶原生物合成若干参数的影响。用肼屈嗪处理的细胞合成的前胶原严重缺乏羟脯氨酸和羟赖氨酸,表明细胞中的脯氨酰和赖氨酰羟化酶反应受到抑制。然而,脯氨酰和赖氨酰羟化酶活性测定显示,肼屈嗪处理的细胞中这些酶的水平显著升高。在细胞提取物中无法模拟肼屈嗪的刺激作用,表明其作用需要完整的细胞。这种作用在96小时内缓慢发生,并且依赖于10至100微摩尔的肼屈嗪浓度。在赖氨酰羟化酶缺陷型突变体中也观察到了这种现象。在正常细胞和突变细胞中,培养基中的抗坏血酸均可改变肼屈嗪作用的相对强度。抗坏血酸使脯氨酰羟化酶对肼屈嗪的反应从1.5至2倍增加到3至7倍,而使赖氨酰羟化酶对肼屈嗪的反应从4至8倍降低到2至3倍。在肼屈嗪处理的细胞中,总胶原合成显著减少;其时间进程和剂量反应关系与羟化酶的相似。铁螯合剂α,α'-联吡啶模拟了肼屈嗪的这些作用。这些研究表明,在培养细胞中存在一种胶原生物合成中这些关键酶过量产生的补偿机制,在患有羟赖氨酸缺乏性胶原病患者的细胞中该机制仍然发挥作用。